Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Blue Sky Uranium Expands Drill Plan to Advance the Ivana Uranium-Vanadium Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Healthcare Biotechnology
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early-to-late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:CPH)

Cipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayment

Canada NewsWire 6 days ago

Cipher Pharmaceuticals Schedules Q1 2025 Earnings Release and Conference Call

Canada NewsWire 12 days ago

Cipher Pharmaceuticals Announces Normal Course Issuer Bid, Including Intention to Utilize Block Purchases

Canada NewsWire 13 days ago

Cipher Pharmaceuticals' Natroba granted Medicaid preferred status in Illinois

Trevor Abes  April 29, 2025

Cipher Pharmaceuticals Secures Medicaid Step-Through Preferred Status for Natroba(TM) in the state of Illinois

Canada NewsWire April 29, 2025

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results

Canada NewsWire March 18, 2025

Cipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call

Canada NewsWire March 11, 2025

Cipher Pharmaceuticals Partner Moberg Pharma AB Reports Topline Data in MOB-015 Phase 3 Study

Canada NewsWire December 10, 2024

Cipher Pharmaceuticals Reports Third Quarter 2024 Results

Canada NewsWire November 7, 2024
View More News ››

Opinion & Analysis (TSX:CPH)

Morning Market Outlook for Aug. 1, 2024

TheUpTrend August 1, 2024

Embrace low-cap biotech for high gains: Eden Rahim of Next Edge Capital

The Life Sciences Report March 2, 2016

How Cipher Pharmaceuticals Is Developing Products for Dermatological Disorders

Dan Levy November 16, 2015

Stockhouse Research: DirectCash craziness and Cipher generic drug battles

Chris Parry September 19, 2013
View More Opinion ››

Bullboard Posts (TSX:CPH)

RE:RE:RE:RE:Dean@PettyCash , Substack

Yes i agree, from a pespective of revenu's missing it would have been much more valuable if the counpond would have worked, but that&...
Alex1726 - 1 day ago

RE:RE:RE:Dean@PettyCash , Substack

I wouldn't call losing out on $50 million USD in potential revenue for MOB-015 in Canada "nothing". https://www...
drewmumaw - 1 day ago

RE:RE:Dean@PettyCash , Substack

Not a huge one, they've lost $500k it's nothing.
Alex1726 - 2 days ago

RE:Dean@PettyCash , Substack

MOB-015 phase 3 failure was a huge gut punch.
drewmumaw - 4 days ago

Dean@PettyCash , Substack

 ...
Possibleidiot01 - 5 days ago

RE:Very good company.

And, based on the call this morning, several licensing deals for Natroba are in the works.
drewmumaw - 5 days ago
View more Bullboard ››

EnviroGold Global Limited.

EnviroGold Global Limited.

EnviroGold Global Limited is a Canadian headquartered clean technology company with a global vision and a strategic focus ...
View More »